// App-Quantinova.ai

1417 : Combination cancer immunotherapy using checkpoint blockade and intratumoral virus-like particles containing CpG ODN

Researchers

Presenter

  • Caitlin Lemke

Principal Investigators

  • Aliasger Salem

  • Arthur Krieg

  • George Weiner

Medical Centers

  • University of Iowa, Iowa City, IA

  • Checkmate Pharmaceuticals, Cambridge, MA

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Solid malignancies

Biomarkers

  • Programmed cell death protein 1

  • Programmed death-ligand 1

  • Cytotoxic T-lymphocyte-associated protein 4

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved